Study Group: Physicians who Treat Diabetic Foot Ulcers
Council Members in this Study Group: 54
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- George Deitrick, MD
Assistant Professor of Surgery
MOUNT SINAI SCHOOL OF MEDICINE OF
George Deitrick, MD, is the Director of Wound Healing Program at the James J. Peters VA Medical Center (Bronx Veterans Medical Research Foundation) in the Bronx, New York. Dr. Deitrick is a General Surgeon and Spinal Cord Injury Physician. He is also an Assistant Professor of Surgery at Mount Sinai...
Thomas Serena, MD, FACSFounder & Medical Director
Penn North Centers For Advanced Wound CareThomas E. Serena, MD, FACS, is Founder and Medical Director of the Penn North Centers for Advanced Wound Care. He is also a Professor at Gannon University in Pennsylvania, where he has established a state-of-the-art research program, including development of a novel acute wound-healing model. Dr. Serena...
John Litton Jr., MDChief Executive Officer and President
Litton Family Medicine, PCJ. Scott Litton, Jr., MD, FAAFP, is the Chief Executive Officer and President of Litton Family Medicine, PC in Pennington Gap, VA. He provides inpatient services and also serves as the Medical Director of the Center for Wound Care at Lee Regional Medical Center. Dr. Litton serves as a Faculty member...
David Armstrong, DPM, MD, PhDProfessor of Surgery and Director, SALSA
University of Arizona College of Medicine - CCDavid Armstrong, DPM, MD, PhD, is a Professor of Surgery and Director, SALSA at The University of Arizona College of Medicine, where he is working since June 2008. Dr. Armstrong also holds an MSc in Tissue Repair and Wound Healing from the University of Wales and a PhD from the University of Manchester,...
Alan Zaccaria, MDPlastic Surgeon
MD ALAN FACS ZACCARIAAlan Zaccaria, MD, FACS, is a double board certified Plastic Surgeon, in private practice in Little Silver, New Jersey. Dr. Zaccaria has expertise in breast reconstruction, breast implants, general reconstructive surgery, facial surgery, cosmetic surgery, skin cancer, botox and injectibles, comprehensive...
GLG NewsSM Analyses by this Study Group's Leading Experts (?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Saxagliptin - third gliptin on the EU market
October 8, 2009
ONGLYZA™ (saxagliptin) Receives Marketing Authorisation In Europe For The Treatment Of Type 2 Diabetes | www.pipelinereview.com
Besides Sitagliptin and Vildagliptin there will be now a 3rd gliptin available in Europe. Whereas vildagliptin officially needs monitoring of the liver enzymes, at least according to the P.I., and there are new warnings for pancreatitis for sitagliptin no such limitations are known to me at the moment....
-
Watchman trial: right device, wrong patient population.
April 3, 2009
ACC: Device May Prevent Stroke in AF Patients | www.medpagetoday.com
1. Left atrial appendage is not the only source of systemic thromboemboli. Thrombi form in the rest of the left atrium and even in the ventricle. 2. The trial did not address issues of thrombogenicity of the device by itself. 3. "Pericardial effusion" was not an effusion, but a bleeding from the...
-
April 3, 2009
U.S. Hospitals Slow to Adopt E-Records | online.wsj.com
While the majority of hospitals have some degree of EMR, none have truly "fully functional" EMR. EMR: 1. Do not increase profit, do not increase productivity, do not save time, do not increase quality of care; 2. Do increase potential for litigations, do increase degree of control of clinicians...
-
Darusentan and Resistant Hypertension
April 2, 2009
Phase III Study of Gilead's Darusentan for Resistant Hypertension Meets Primary Endpoints | investors.gilead.com
The most recent press release from Gilead Scienes, Inc. (Nasdaq: GILD) re: phase III study of Darusentan, a novel endothelin receptor antagonist, designed to control resistant hypertension. The effectiveness in controlling systemic blood pressure was found to be statistically significant. Incidence...
-
A Low Cost EMR System From Wal-Mart?
March 16, 2009
Alan Zaccaria, MD, Plastic Surgeon, MD ALAN FACS ZACCARIA
Wal-Mart Plans to Market Digital Health Records System | www.nytimes.com
Wal-Mart is one of the top consumer retailers in the country. They have already entered the world of competitive, low cost health care delivery with their $4.00 generic prescriptions and their Nurse Practitioner run clinics--so becoming a warehouse for state-of-the-art electronic medical...
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
- Government/Military Hospital or Clinic
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Director
- Owner
- Physician - Division Head
- Podiatrist